These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Agonist-specific regulation of mu-opioid receptor desensitization and recovery from desensitization. Virk MS; Williams JT Mol Pharmacol; 2008 Apr; 73(4):1301-8. PubMed ID: 18198283 [TBL] [Abstract][Full Text] [Related]
43. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells. Onoprishvili I; Andria ML; Vilim FS; Hiller JM; Simon EJ Brain Res Mol Brain Res; 1999 Nov; 73(1-2):129-37. PubMed ID: 10581406 [TBL] [Abstract][Full Text] [Related]
44. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists. Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334 [TBL] [Abstract][Full Text] [Related]
45. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine. Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975 [TBL] [Abstract][Full Text] [Related]
46. Opioid receptor subtype involvement in maternal behavior in lactating rats. Mann PE; Kinsley CH; Bridges RS Neuroendocrinology; 1991 May; 53(5):487-92. PubMed ID: 1651460 [TBL] [Abstract][Full Text] [Related]
47. Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells. Wang Q; Liu-Chen LY; Traynor JR J Biol Chem; 2009 Jul; 284(27):18357-67. PubMed ID: 19416973 [TBL] [Abstract][Full Text] [Related]
48. Adaptations to chronic agonist exposure of mu-opioid receptor-expressing Chinese hamster ovary cells. Kato S; Fukuda K; Morikawa H; Shoda T; Mima H; Mori K Eur J Pharmacol; 1998 Mar; 345(2):221-8. PubMed ID: 9600641 [TBL] [Abstract][Full Text] [Related]
49. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells. Mandyam CD; Altememi GF; Standifer KM Eur J Pharmacol; 2000 Aug; 402(1-2):R1-37. PubMed ID: 10940375 [TBL] [Abstract][Full Text] [Related]
50. Shadows across mu-Star? Constitutively active mu-opioid receptors revisited. Connor M Br J Pharmacol; 2009 Apr; 156(7):1041-3. PubMed ID: 19368530 [TBL] [Abstract][Full Text] [Related]
51. Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: a potential expression system for large-scale production of G-protein coupled receptors. Perret BG; Wagner R; Lecat S; Brillet K; Rabut G; Bucher B; Pattus F Protein Expr Purif; 2003 Sep; 31(1):123-32. PubMed ID: 12963349 [TBL] [Abstract][Full Text] [Related]
52. Role of agonist-dependent receptor internalization in the regulation of mu opioid receptors. Sternini C; Brecha NC; Minnis J; D'Agostino G; Balestra B; Fiori E; Tonini M Neuroscience; 2000; 98(2):233-41. PubMed ID: 10854754 [TBL] [Abstract][Full Text] [Related]
53. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors. Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951 [TBL] [Abstract][Full Text] [Related]
54. Modulating micro-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKCepsilon activation and dendritic spine stability. Zheng H; Chu J; Zhang Y; Loh HH; Law PY J Biol Chem; 2011 Apr; 286(14):12724-33. PubMed ID: 21292762 [TBL] [Abstract][Full Text] [Related]
55. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value. Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397 [TBL] [Abstract][Full Text] [Related]
56. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells. Yu VC; Eiger S; Duan DS; Lameh J; Sadée W J Neurochem; 1990 Oct; 55(4):1390-6. PubMed ID: 1697894 [TBL] [Abstract][Full Text] [Related]
57. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects. Locke KW; Holtzman SG J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230 [TBL] [Abstract][Full Text] [Related]
58. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor. Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761 [TBL] [Abstract][Full Text] [Related]
59. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor. Smith MA; Barrett AC; Picker MJ Psychopharmacology (Berl); 1999 Apr; 143(3):261-9. PubMed ID: 10353428 [TBL] [Abstract][Full Text] [Related]
60. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins. Melkes B; Hejnova L; Novotny J Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]